Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by GoldenHawkon Jun 27, 2018 4:41pm
153 Views
Post# 28240141

RE:Bold prediction

RE:Bold predictionI like your optimism but I think you are selling yourself short ( hopefully not shares ;) 

Way too much going on here! I see it doing better than .225 and even better leading up to the long weekend! Again, results are on the way and are expected to be bigger and better than the last two 
releases. Funding coming in and no pp needed. It’s a winner now and a green unicorn in time!

DrHoliday wrote: I`ll stick my neck out here, and predict that ICO will trade on heavy volume again tomorrow with another green candle and close at .225. 

At .225 cents, this is still a modest valuation of $19 million CDN, especially with Oral B Amphotericin on it`s way to corner the market and save millions of people from disease and suffering.

A $100 million market cap would yield a price of $1.20 CDN based on the current 84 mil outstanding. In a billion dollar market for this drug, it is entirely reasonable to think this possible.

DOC.


<< Previous
Bullboard Posts
Next >>